The State of the U.S. Biomedical and Health Research Enterprise: Strategies for Achieving a Healthier America

The U.S. biomedical research enterprise contributes significantly to the nation’s health and economy. An NAM committee conducted a thorough review to determine whether the enterprise can continue to lead globally and address our population’s health needs in the face of complex challenges. This report presents the results of that review and lays out strategies to reimagine and reinvigorate the biomedical research enterprise before a moment of crisis. In this webinar hosted by NAM President Victor Dzau, a panel of committee members will present an overview of the report followed by a discussion with national leaders in biomedical research.

Access the event here on October 1: https://nasem.zoom.us/j/95603512700?pwd=J54eSRkTla1dvzLtPqWxxpKIKKLMSd.1

Agenda:

Welcome:

• Victor J. Dzau, National Academy of Medicine

Overview of Report Findings:

• E. Albert Reece (Committee Chair), University of Maryland School of Medicine
• Ann Kurth, The New York Academy of Medicine
• Sudip Parikh, American Association for the Advancement of Science
• Elias Zerhouni, Johns Hopkins University

Discussion with National Leaders in Biomedical Research:

• Victor J. Dzau (Moderator), National Academy of Medicine
• Monica Bertagnolli, National Institutes of Health
• Kimryn Rathmell, National Cancer Institute
• John Reed, Johnson & Johnson
• Robert Conn, University of California, San Diego